$15.26
arrow_drop_down1.16%Key Stats | |
---|---|
Open | $15.49 |
Prev. Close | $15.44 |
EPS | -1.47 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 14.51 | 15.64 |
52 Week Range | 2.10 | 19.10 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.47 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Wall Street Analysts Think Perspective Therapeutics (CATX) Could Surge 80.31%: Read This Before Placing a Bet - Zacks Investment Research
Perspective Therapeutics Announces Inclusion in the Russell 3000® Index
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annual Meeting
Perspective Therapeutics Announces Pricing of $80 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
Perspective Therapeutics to Participate at Upcoming May Investor Conferences